Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Behavior × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Neoplasms 12 Leukemia, Myeloid, Acute 9 Ovarian Neoplasms 6 Lung Neoplasms 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Multiple Myeloma 5 Lymphoma 5 Stomach Neoplasms 4 Neoplasm Metastasis 4 Leukemia 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Glioblastoma 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Peritoneal Neoplasms 2 Pain 2 Motor Activity 2 Melanoma 2 Genital Neoplasms, Female 2

Interventions

Counseling 3 Motivational Interviewing 2 College Fraternities and Sororities 2 Transportation 1 Spermine Synthase 1 Risk Factors 1 Risk Assessment 1 Riluzole 1 Price Transparency 1 Precision Medicine 1 Palliative Care 1 Methods 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 House Calls 1 Exercise 1 Ethanol 1 Educational Status 1 Decision Support Techniques 1 Cannabidiol 1 Acceptance and Commitment Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡